[ExI] glutamine and life-extension

Stathis Papaioannou stathisp at gmail.com
Tue Feb 16 21:38:12 UTC 2010

On 17 February 2010 02:03, Dave Sill <sparge at gmail.com> wrote:
> On Tue, Feb 16, 2010 at 3:35 AM, Stathis Papaioannou <stathisp at gmail.com> wrote:
>> ... Nevertheless, my bias is to follow conventional
>> medicine, and only rarely does conventional medicine consider that
>> there is enough evidence to recommend treatments with dietary
>> supplements. A common response to this is that medical professionals
>> are unduly influenced by drug companies, and there may be some truth
>> to that, but I work in the public health system where there is an
>> explicit emphasis on using the cheapest effective treatment: amino
>> acids in bulk are very cheap compared to most drugs, and they would be
>> used if there were good evidence for their efficacy.
> So who is motivated to research therapeutic effects of cheap
> supplements? Drug companies are motivated by the profit potential of a
> new, exclusive drug. There are no big payoffs in researching cheap
> supplements.

Medical researchers, usually publicly or not-for-profit funded.

Stathis Papaioannou

More information about the extropy-chat mailing list